Anthony King
I am a freelance science journalist based in Dublin, Ireland. I cover a variety of topics in chemical and biological sciences, as well as science policy, health and innovation.
My articles have appeared in Nature, Science, Cell, Chemistry World, New Scientist, the Irish Times, New York Times, EMBO Reports, Chemistry & Industry and more.
I enjoy writing on a wide breadth of subjects, from antibiotics to petrochemicals, bumblebees to asteroid composition, palaeontology to brain development. Previously I worked for a publishing company as a science editor.
My primary degree in science is from Trinity College Dublin and I hold a Master’s degree in science communications from Dublin City University.
NewsEuropean parliament restores research funding
Extra funding found for Horizon Europe and Erasmus student programme
- News
World Health Organization takes aim at market as many still not getting vaccines they need
Government, industry and health organisations must do more
- Research
Gut bacterium found to destroy nicotine offers liver health benefits for smokers
Discovery might lead to therapy for non-alcoholic fatty liver disease
- News
EU plots course to secure raw materials vital to a low-carbon economy
Russia’s war on Ukraine and the pandemic have highlighted the bloc’s dependence on unreliable suppliers
- Research
Electrolyser conjures hydrogen from thin air for green energy
Device can capture water to split even in regions as dry as the Sahel
- Business
Nature-inspired crop protection
Plant extracts, proteins and pheromones aiming to replace conventional chemical pesticides
- Business
UK Reach costs stretch higher for industry
Government assessment suggests deadlines will be delayed and companies will pay billions for compliance data
- Research
Solar jet fuel production from CO2 and water scaled up in field demo
Concentrated solar power provide heat to reduce carbon dioxide to a fuel
- Business
Haleon emerges from GSK consumer healthcare spin-off
Split illustrates move towards narrower focus in pharmaceuticals
- Research
Renewable rocket fuel made by genetically engineered soil bacteria
Bioengineered bacteria synthesise extremely energy dense cyclopropane chains
- Business
Novartis cutting up to 8000 jobs
Restructure splits commercial activities geographically instead of by treatment area
- News
European commission proposal seeks to cut EU pesticide use in half by 2030
Ambitious targets will rely on roll-out of integrated pest management techniques and extra payments to farmers
- News
New questions raised over Sputnik Covid vaccine results point to fraudulent practices
Analysis comparing Sputnik results with five other Covid vaccines finds phase 3 trial outcome is highly improbable
- Business
Soapbark branches out to fill essential role in vaccine recipes
The soapbark tree has long been used in traditional medicines, but is now coveted for some of our newest vaccines
- News
Question marks over cannabidiol’s safety in food, European agency finds
Food safety body has already received more than 150 applications to add CBD to food products
- Research
Gene therapy showcases technique to extend life in mice
Lab mice lived significantly longer after receiving one of two genes, delivered using a mouse herpes virus
- Business
What is the future of Covid-19 pharmaceuticals?
Firms anticipate long-term markets for prevention and treatment
- News
Hope stirs anew for Australian research following election
Labor party’s win leads to cautious optimism about science funding and climate policies
- Research
All of life’s nucleic acids could have extraterrestrial origins
All five nucleobases of RNA and DNA found in three meteorites
- Business
UK takes subscription approach for new antibiotics
Decoupling payment from prescriptions helps preserve last-line antibiotics and encourage R&D
